Navigation Links
European Urological Device Market Will Be Driven By Adoption Of New Minimally Invasive Devices
Date:8/1/2013

TORONTO, Aug. 1, 2013 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, patient and hospital demand for minimally invasive and discreet devices is rising within European markets for urological devices, and products that meet these needs are poised to see strong adoption through 2021.

(Logo:  http://photos.prnewswire.com/prnh/20130103/MM36799LOGO)

Minimally invasive products stand to gain significant adoption because these devices require shorter operation times and result in reduced patient pain. For example, EDAP TMS' Focal.One high-intensity focused ultrasound (HIFU) system, which received CE marking in June 2013, uses advanced imaging and robotic technology to target specific areas of the prostate for prostate cancer treatment. This product will help to address the demand for less invasive focal prostate cancer therapy, which can potentially reduce complications because the entire gland is not treated. The Focal.One will therefore see growing adoption through 2021.

"The demand for minimally invasive treatments is also driving a shift toward flexible endoscopy for many procedures," said MRG Analyst Jennifer Smith. "Flexible endoscopy decreases tissue trauma and can reach more anatomy than is possible during rigid endoscopy. The increasing use of this treatment will support demand for flexible endoscopes as well as for devices used during flexible endoscopy procedures, like tipless nitinol stone retrieval devices and holmium lasers used in stone management procedures."

In addition, many innovations are aimed at making urological devices more discreet, given that patients are self-conscious about these products. The urinary incontinence device market in particular has seen a marked shift toward discreet devices; intermittent catheters generated the majority of revenues in this segment in 2012 because these devices allow for self-catheterization and also offer a reduced risk of urinary tract infections compared to Foley catheters. An example of an innovation in this space is Coloplast's Speedicath Compact Set, a product that is designed to make catheterization more discreet for wheelchair users.

Millennium Research Group's European Markets for Urological Devices 2013 and European Markets for Urological Devices 2013 (Part 2) reports include procedure, unit, average selling price and revenue information, along with market drivers and limiters and a competitive landscape for urinary incontinence devices, stone management devices, benign prostatic hyperplasia devices, urological endoscopes, prostate cancer treatment devices and erectile dysfunction treatment devices in France, Germany, Italy, Spain, the United Kingdom, Belgium, the Netherlands, Sweden and Switzerland. Supplemental country coverage is also available for Austria, the Czech Republic, Denmark, Finland, Greece, Hungary, Norway, Poland, Portugal, Romania and Ukraine, as well as in aggregate for the rest of the European countries.

About Millennium Research Group
Millennium Research Group (www.MRG.net), a Decision Resources Group company (www.DecisionResourcesGroup.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack™ projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Christopher Comfort
Decision Resources Group
781-993-2597
ccomfort@dresources.com

Alex Jablokow
Millennium Research Group
617-599-8613
ajablokow@mrg.net


'/>"/>
SOURCE Millennium Research Group
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
2. Biodels Intellectual Property Position Strengthened for Ultra-Rapid-Acting Insulin Programs by Notice of Intent to Grant from European Patent Office
3. Marken Acquires European Kit Building Operation From LabCorp Clinical Trials
4. Blood Disorders: European Hematologists Gather in Amsterdam, June 14-17, 2012
5. Mylan Launches Generic Lipitor® in Five European Countries
6. European Thrombosis Therapeutics Market is Experiencing an Urgent Need for Enhanced Products, Says Frost & Sullivan
7. Bristol-Myers Squibb to Present New Data on ORENCIA(R)? (abatacept) at the European League Against Rheumatism (EULAR) 2012 Congress
8. Cardium Announces Agreement With UK-Based Angel Biomedical For Excellagen Supply And Planned European Market Expansion
9. Study Results of Novocures NovoTTF™ Pivotal Phase 3 Trial Published in European Journal of Cancer
10. Cardiac Dimensions® Announces Publication of TITAN Clinical Trial Data in European Journal of Heart Failure
11. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... , March 22, 2017 Under the ... pharmaceutical packaging market size increased year by year ... 2017 to 2021, the market size will maintain ... expected to outnumber RMB140 billion in 2021, thanks ... rapid development of biological agents and supporting policies. ...
(Date:3/22/2017)... PRINCETON, N.J. , March 22, 2017 ... systems averted 77,342 cases of patient harm and saved ... thanks to their participation in a national quality improvement ... of progress under Partnership for Patients-New Jersey, part of ... and Human Services. HHS selected the New Jersey Hospital ...
(Date:3/22/2017)... 2017 Research and Markets has announced ... Market & Clinical Pipeline Insight 2022" drug pipelines to ... ... Pipeline Insight 2022 report gives comprehensive insight on clinical and ... check point inhibitors as main streamline drugs in the immunotherapy ...
Breaking Medicine Technology:
(Date:3/22/2017)... Angeles, CA (PRWEB) , ... March 22, 2017 ... ... information community, announces the publication of the first issue of its companion print ... educate the public about cosmetic surgery thanks to information provided by board-certified doctors ...
(Date:3/22/2017)... San Francisco, CA (PRWEB) , ... March 22, ... ... headquartered in the California Bay Area providing insurance assistance, financial planning, and related ... conjunction with Endangered Species International to promote awareness of threatened species and wild ...
(Date:3/22/2017)... ... March 22, 2017 , ... The American Society ... authorization (PA) form for prescribers to improve patients’ access to the revolutionary therapy ... published as part of the article entitled “PCSK9 Inhibitor Access Barriers: Issues ...
(Date:3/22/2017)... ... 2017 , ... Soriant recognizes that identifying savings opportunities can ... facilities across the country are always forced to focus on costs and budgets. ... country, an efficient and quick way to estimate savings potential within specific support ...
(Date:3/22/2017)... ... March 22, 2017 , ... In recognition ... print media enterprise focused on cancer patients, cancer centers and advocacy groups, and ... 12-part educational video series, “No Ifs, Ands, or Butts,” that focuses on Colorectal ...
Breaking Medicine News(10 mins):